2000
DOI: 10.1053/gast.2000.18017
|View full text |Cite
|
Sign up to set email alerts
|

SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

15
378
5
14

Year Published

2003
2003
2019
2019

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 464 publications
(412 citation statements)
references
References 34 publications
15
378
5
14
Order By: Relevance
“…Mutations in the best characterized risk genes PRSS1 (cationic trypsinogen), SPINK1 (pancreatic secretory trypsin inhibitor), and CTRC (chymotrypsin C) stimulate activation of trypsinogen and result in elevated trypsin activity in the pancreas [4][5][6][7][8][9]. More recently, loss-of-function variants in the CPA1 gene encoding carboxypeptidase A1 were shown to increase risk for early onset CP [10].…”
Section: Introductionmentioning
confidence: 99%
“…Mutations in the best characterized risk genes PRSS1 (cationic trypsinogen), SPINK1 (pancreatic secretory trypsin inhibitor), and CTRC (chymotrypsin C) stimulate activation of trypsinogen and result in elevated trypsin activity in the pancreas [4][5][6][7][8][9]. More recently, loss-of-function variants in the CPA1 gene encoding carboxypeptidase A1 were shown to increase risk for early onset CP [10].…”
Section: Introductionmentioning
confidence: 99%
“…This result is similar to that reported by Audrézet et al, 7 who reported the presence of the N34S mutation in 10% of ICP patients, and by Ockenga et al, 12 who reported a similar prevalence of SPINK1 mutations in a cohort of adult IP patients. A higher frequency of SPINK1 mutations was described by Witt et al 5 and by Pfützer et al, 6 where the frequency of N34S in CP patients was 18.75 and 40.3%, respectively.…”
Section: Resultsmentioning
confidence: 72%
“…The À41G4A variant, which was present in one IP and in no control individual, has been discussed by Audrézet et al 7 as having a possible role in transcription efficiency of the protein. However, it was also present in 6 so its relevance in IP remains to be determined. Interestingly, the N34S mutation was present in two patients who carried the 5T variant and in one who carried the L997F variant in the CFTR gene ( Table 2).…”
Section: Resultsmentioning
confidence: 99%
“…Hereditary pancreatitis often is associated with various mutations in the cationic trypsinogen gene that could render trypsinogen either more prone to premature activation or may render active trypsin more resistant to degradation by other proteases [32,33]. Mutations in the serine protease inhibitor, Kazal type 1 gene that might render pancreatic secretory trypsin inhibitor (PSTI) less effective are associated with certain forms of chronic pancreatitis [34][35][36].…”
Section: The Mechanism and Intracellular Site Of Zymogen Activationmentioning
confidence: 99%